Healthcare provider profile · identity verified

Ralph Tremaglio, MD

Allopathic & Osteopathic Physicians|Internal Medicine · NAUGATUCK, CT · NPI 1053360305

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Ralph Tremaglio, MD received $85.40 in general payments during 2025 across 5 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Jardiance by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$85.40

5 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$85.40	100.0%	5	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$85.40	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$85.40	5	2025
Source payment records 2025-02-05 · Boehringer Ingelheim Pharmaceuticals, Inc. · $16.29 · Open Payments source 2025-02-26 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.07 · Open Payments source 2025-03-25 · Boehringer Ingelheim Pharmaceuticals, Inc. · $20.58 · Open Payments source 2025-07-23 · Boehringer Ingelheim Pharmaceuticals, Inc. · $15.16 · Open Payments source 2025-09-10 · Boehringer Ingelheim Pharmaceuticals, Inc. · $15.30 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	41	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	41	13

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	432	99
Amlodipine Besylate	Amlodipine Besylate	349	88
Atorvastatin Calcium	Atorvastatin Calcium	250	64
Rosuvastatin Calcium	Rosuvastatin Calcium	239	60
Hydrochlorothiazide	Hydrochlorothiazide	224	55
Metformin Hcl	Metformin Hcl	204	54
Lisinopril	Lisinopril	197	53
Lorazepam	Lorazepam	197	40
Pantoprazole Sodium	Pantoprazole Sodium	183	51
Metoprolol Succinate	Metoprolol Succinate	179	46
Gabapentin	Gabapentin	142	30
Simvastatin	Simvastatin	140	39
Alprazolam	Alprazolam	138	23
Tamsulosin Hcl	Tamsulosin Hcl	134	30
Losartan Potassium	Losartan Potassium	128	31
Omeprazole	Omeprazole	123	26
Montelukast Sodium	Montelukast Sodium	116	20
Zolpidem Tartrate	Zolpidem Tartrate	105	19
Allopurinol	Allopurinol	96	20
Baclofen	Baclofen	96	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	27
Sertraline Hcl	Sertraline Hcl	91	22
Torsemide	Torsemide	89	19
Meloxicam	Meloxicam	86	16
Eliquis	Apixaban	80	14
Famotidine	Famotidine	76	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	14
Albuterol Sulfate Hfa	Albuterol Sulfate	74	17
Trazodone Hcl	Trazodone Hcl	74	23
Tramadol Hcl	Tramadol Hcl	73	19
Metoprolol Tartrate	Metoprolol Tartrate	72	17
Metformin Hcl Er	Metformin Hcl	71	20
Pravastatin Sodium	Pravastatin Sodium	70	16
Glimepiride	Glimepiride	68	19
Citalopram Hbr	Citalopram Hydrobromide	65	15
Januvia	Sitagliptin Phosphate	61	11
Methylprednisolone	Methylprednisolone	61	56
Nebivolol Hcl	Nebivolol Hcl	61	suppressed
Diazepam	Diazepam	59	11
Xarelto	Rivaroxaban	55	suppressed
Phenobarbital	Phenobarbital	53	suppressed
Labetalol Hcl	Labetalol Hcl	51	15
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Farxiga	Dapagliflozin Propanediol	50	14
Chlorthalidone	Chlorthalidone	49	13
Prednisone	Prednisone	49	25
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	12
Potassium Chloride	Potassium Chloride	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	47	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	46	suppressed
Cefuroxime	Cefuroxime Axetil	46	38
Donepezil Hcl	Donepezil Hcl	46	suppressed
Furosemide	Furosemide	45	20
Synthroid	Levothyroxine Sodium	44	13
Mirtazapine	Mirtazapine	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Carvedilol	Carvedilol	41	suppressed
Jardiance	Empagliflozin	41	13
Tradjenta	Linagliptin	41	suppressed
Enalapril Maleate	Enalapril Maleate	38	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	36	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	35	suppressed
Promethazine Hcl	Promethazine Hcl	34	suppressed
Cefadroxil	Cefadroxil	33	28
Clonazepam	Clonazepam	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Lansoprazole	Lansoprazole	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	33	suppressed
Ketoconazole	Ketoconazole	32	13
Azithromycin	Azithromycin	31	30
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	30	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	11
Cephalexin	Cephalexin	28	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Nabumetone	Nabumetone	26	suppressed
Risperidone	Risperidone	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Rizatriptan	Rizatriptan Benzoate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	15
Levofloxacin	Levofloxacin	23	18
Benazepril Hcl	Benazepril Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Doxycycline Hyclate	Doxycycline Hyclate	20	18
Lactulose	Lactulose	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Finasteride	Finasteride	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Febuxostat	Febuxostat	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Zaleplon	Zaleplon	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Ammonium Lactate	Ammonium Lactate	14	suppressed
Ozempic	Semaglutide	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amiloride Hcl	Amiloride Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Valsartan	Valsartan	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Budesonide	Budesonide	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Estradiol	Estradiol	11	suppressed
Juluca	Dolutegravir/Rilpivirine	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Primidone	Primidone	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$85.40 · 5 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error